Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRBC Transfusion During Prolonged Adult In-hospital Cardiac Arrest
NCT06462027Phase 1Suspended
- Sponsor
- NYU Langone Health
- Start
- Jun 2026
- Primary completion
- Jul 2027
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of red blood cells in cardiac arrest (SCA) (3 arms), sponsored by NYU Langone Health. Primary endpoints: Time to administration of Packed Red Blood Cells up to 20 minutes, Frequency of antibody-mediated transfusion reactions and 4 more. Started Jun 2026; status: suspended.
02
Drugs
red blood cells
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT06462027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06462027.